Literature DB >> 21074481

Role of IL-15 in immune-mediated and infectious diseases.

Antonio Di Sabatino1, Sandra A Calarota, Francesca Vidali, Thomas T Macdonald, Gino R Corazza.   

Abstract

IL-15 has a broad spectrum of biological activities. It is crucial for the development, proliferation, survival and differentiation of multiple cells from both innate and adaptive immune systems. However, IL-15 up-regulation has a central role in the development of several autoimmune or chronic inflammatory disorders. Therefore, targeting IL-15 or its receptor may have a valuable impact on the treatment of immune-mediated diseases. On the other hand, in some infectious diseases, IL-15 production is compromised but IL-15 given exogenously can potentially enhance immune responses to pathogens. Here, we discuss the current understanding of IL-15 role in immune-mediated and infectious diseases as well as its therapeutic use.
Copyright © 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21074481     DOI: 10.1016/j.cytogfr.2010.09.003

Source DB:  PubMed          Journal:  Cytokine Growth Factor Rev        ISSN: 1359-6101            Impact factor:   7.638


  33 in total

Review 1.  Type I IFN-mediated regulation of IL-1 production in inflammatory disorders.

Authors:  Kristina Ludigs; Valeriy Parfenov; Renaud A Du Pasquier; Greta Guarda
Journal:  Cell Mol Life Sci       Date:  2012-04-24       Impact factor: 9.261

Review 2.  The role of interleukin-15 in inflammation and immune responses to infection: implications for its therapeutic use.

Authors:  Pin-Yu Perera; Jack H Lichy; Thomas A Waldmann; Liyanage P Perera
Journal:  Microbes Infect       Date:  2011-10-25       Impact factor: 2.700

3.  Uropathogenic E. coli promote a paracellular urothelial barrier defect characterized by altered tight junction integrity, epithelial cell sloughing and cytokine release.

Authors:  M W Wood; E B Breitschwerdt; S K Nordone; K E Linder; J L Gookin
Journal:  J Comp Pathol       Date:  2011-10-19       Impact factor: 1.311

4.  IL-15 receptor α signaling constrains the development of IL-17-producing γδ T cells.

Authors:  Sara L Colpitts; Lynn Puddington; Leo Lefrançois
Journal:  Proc Natl Acad Sci U S A       Date:  2015-07-20       Impact factor: 11.205

5.  IL-15 temporally reorients IL-10 biased B-1a cells toward IL-12 expression.

Authors:  Amlan Kanti Ghosh; Debolina Sinha; Subhadeep Mukherjee; Ratna Biswas; Tapas Biswas
Journal:  Cell Mol Immunol       Date:  2015-03-09       Impact factor: 11.530

6.  The role of IL-15 in activating STAT5 and fine-tuning IL-17A production in CD4 T lymphocytes.

Authors:  Pushpa Pandiyan; Xiang-Ping Yang; Senthil S Saravanamuthu; Lixin Zheng; Satoru Ishihara; John J O'Shea; Michael J Lenardo
Journal:  J Immunol       Date:  2012-09-19       Impact factor: 5.422

7.  IL-15 induces alloreactive CD28(-) memory CD8 T cell proliferation and CTLA4-Ig resistant memory CD8 T cell activation.

Authors:  O Traitanon; A Gorbachev; J J Bechtel; K S Keslar; W M Baldwin; E D Poggio; R L Fairchild
Journal:  Am J Transplant       Date:  2014-05-19       Impact factor: 8.086

8.  Potent Cytolytic Activity and Specific IL15 Delivery in a Second-Generation Trispecific Killer Engager.

Authors:  Martin Felices; Todd R Lenvik; Behiye Kodal; Alexander J Lenvik; Peter Hinderlie; Laura E Bendzick; Dawn K Schirm; Michael F Kaminski; Ron T McElmurry; Melissa A Geller; Craig E Eckfeldt; Daniel A Vallera; Jeffrey S Miller
Journal:  Cancer Immunol Res       Date:  2020-07-13       Impact factor: 11.151

9.  Interleukin-15 receptor α expression in inflammatory bowel disease patients before and after normalization of inflammation with infliximab.

Authors:  Clémentine Perrier; Ingrid Arijs; Dominiek Staelens; Christine Breynaert; Isabelle Cleynen; Kris Covens; Marc Ferrante; Gert Van Assche; Séverine Vermeire; Gert de Hertogh; Frans Schuit; Paul Rutgeerts; Jan L Ceuppens
Journal:  Immunology       Date:  2013-01       Impact factor: 7.397

10.  IL-15 Agonists: The Cancer Cure Cytokine.

Authors:  Jennifer Wu
Journal:  J Mol Genet Med       Date:  2013-10-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.